Syndax Pharmaceuticals Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Syndax Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Syndax Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1M, a 49.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1M -$968K -49.2% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.24M +$314K +33.8% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.49M +$448K +43.1% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $1.73M +$579K +50.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.97M +$1.19M +154% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $929K +$56K +6.42% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.04M +$56K +5.7% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.15M +$59K +5.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $774K +$436K +129% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $873K +$439K +101% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $983K +$693K +239% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.09M +$697K +176% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $338K -$164K -32.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $434K -$174K -28.6% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $290K -$426K -59.5% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $396K -$430K -52.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $502K -$585K -53.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $608K -$600K -49.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $716K -$584K -44.9% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $826K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.09M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.21M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.3M Jan 1, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.